Literature DB >> 30308267

The androgen receptor is required for maintenance of bone mass in adult male mice.

Jianyao Wu1, Petra Henning1, Klara Sjögren1, Antti Koskela2, Juha Tuukkanen2, Sofia Movérare-Skrtic1, Claes Ohlsson3.   

Abstract

Previous studies evaluating the role of the androgen receptor (AR) for bone mass have used mouse models with global or tissue-specific lifelong inactivation of the AR. However, these mouse models have the AR inactivated already early in life and the relative roles of the AR during development, sexual maturation and in adult mice cannot be evaluated separately. The aim of the present study was to determine the specific roles of the AR in bone during sexual maturation and in adult mice. The AR was conditionally ablated at four (pre-pubertal) or ten (post-pubertal) weeks of age in male mice using tamoxifen-inducible Cre-mediated recombination. Both the pre-pubertal and the post-pubertal AR inactivation were efficient demonstrated by substantially lower AR mRNA levels in seminal vesicle, bone and white adipose tissue as well as markedly reduced weights of reproductive tissues when comparing inducible ARKO mice and control mice at 14 weeks of age. Total body BMD, as analyzed by DXA, as well as tibia diaphyseal cortical bone thickness and proximal metaphyseal trabecular bone volume fraction, as analyzed by μCT, were significantly reduced by both pre-pubertal and post-pubertal AR inactivation. These bone effects were associated with an increased bone turnover, indicating a high bone turnover osteoporosis. Pre-pubertal but not post-pubertal AR inactivation resulted in substantially increased fat mass. In conclusion, the AR is required for maintenance of both trabecular and cortical bone in adult male mice while AR expression during puberty is crucial for normal fat mass homeostasis in adult male mice.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Bone; Fat; Inducible

Mesh:

Substances:

Year:  2018        PMID: 30308267     DOI: 10.1016/j.mce.2018.10.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  Incremental Element Deletion-Based Finite Element Analysis of the Effects of Impact Speeds, Fall Postures, and Cortical Thicknesses on Femur Fracture.

Authors:  Yangyang Cui; Dingding Xiang; Liming Shu; Zhili Duan; Zhenhua Liao; Song Wang; Weiqiang Liu
Journal:  Materials (Basel)       Date:  2022-04-14       Impact factor: 3.748

Review 2.  The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.

Authors:  Varun S Venkatesh; Mathis Grossmann; Jeffrey D Zajac; Rachel A Davey
Journal:  Obes Rev       Date:  2022-01-27       Impact factor: 10.867

Review 3.  Bone Health in Men with Prostate Cancer: Review Article.

Authors:  Salma A M El Badri; Abdulazeez Salawu; Janet E Brown
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

4.  Cortical Bone Mass is Low in Boys with Klinefelter Syndrome and Improves with Oxandrolone.

Authors:  Maria G Vogiatzi; Shanlee M Davis; Judith L Ross
Journal:  J Endocr Soc       Date:  2021-02-10

Review 5.  Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review.

Authors:  Tae Jin Kim; Kyo Chul Koo
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

6.  Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.

Authors:  Ye Zhang; Ming-Wei Liu; Yun He; Ning Deng; Yan Chen; Jiecong Huang; Wei Xie
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

7.  BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis.

Authors:  David S Nelson; Ryan L Marano; Yechaan Joo; Sara Y Tian; Bhumi Patel; Daniel H Kaplan; Mark J Shlomchik; Kristen Stevenson; Roderick T Bronson; Barrett J Rollins
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.